DE68906437T2 - L-pyroglutamyl-l-cystein-dipeptid mit hoher anti-cataractogener wirkung und dies enthaltende pharmazeutische zusammensetzungen. - Google Patents

L-pyroglutamyl-l-cystein-dipeptid mit hoher anti-cataractogener wirkung und dies enthaltende pharmazeutische zusammensetzungen.

Info

Publication number
DE68906437T2
DE68906437T2 DE8989103699T DE68906437T DE68906437T2 DE 68906437 T2 DE68906437 T2 DE 68906437T2 DE 8989103699 T DE8989103699 T DE 8989103699T DE 68906437 T DE68906437 T DE 68906437T DE 68906437 T2 DE68906437 T2 DE 68906437T2
Authority
DE
Germany
Prior art keywords
dipeptide
pyroglutamyl
cataractogenic
cystein
effect
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8989103699T
Other languages
English (en)
Other versions
DE68906437D1 (de
Inventor
Giuseppe Dr Benanti
Victor Prof Rizza
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
S I F I IND FARMACEUTI Soc
Original Assignee
S I F I IND FARMACEUTI Soc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by S I F I IND FARMACEUTI Soc filed Critical S I F I IND FARMACEUTI Soc
Publication of DE68906437D1 publication Critical patent/DE68906437D1/de
Application granted granted Critical
Publication of DE68906437T2 publication Critical patent/DE68906437T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C07K5/06173—Dipeptides with the first amino acid being heterocyclic and Glp-amino acid; Derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DE8989103699T 1988-03-15 1989-03-03 L-pyroglutamyl-l-cystein-dipeptid mit hoher anti-cataractogener wirkung und dies enthaltende pharmazeutische zusammensetzungen. Expired - Lifetime DE68906437T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8819783A IT1216096B (it) 1988-03-15 1988-03-15 L_piroglutamil_l_cisteina, dipeptide ad elevata attivita'anticatarattogena e composizioni farmaceutiche che lo contengono.

Publications (2)

Publication Number Publication Date
DE68906437D1 DE68906437D1 (de) 1993-06-17
DE68906437T2 true DE68906437T2 (de) 1993-09-09

Family

ID=11161182

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8989103699T Expired - Lifetime DE68906437T2 (de) 1988-03-15 1989-03-03 L-pyroglutamyl-l-cystein-dipeptid mit hoher anti-cataractogener wirkung und dies enthaltende pharmazeutische zusammensetzungen.

Country Status (5)

Country Link
EP (1) EP0332946B1 (de)
AT (1) ATE89288T1 (de)
DE (1) DE68906437T2 (de)
ES (1) ES2053834T3 (de)
IT (1) IT1216096B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1249650B (it) * 1991-05-29 1995-03-09 Poli Ind Chimica Spa N-(5-tioxo-l-prolil)-l-cisteina e suoi derivati, loro preparazione ed impiego terapeutico
IT1256178B (it) * 1992-11-30 1995-11-29 Lorenzo Ferrari Composti ad attivita' terapeutica utili per il trattamento di malattieconnesse ad una carenza di glutatione, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
US5624955A (en) * 1995-05-03 1997-04-29 Regents Of The University Of Minnesota Compounds that enhance the concentration of glutathione in tissues

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT40447A (en) * 1984-03-29 1986-12-28 Sandoz Ag Process for preparing substituted alpha-amino acids and pharmaceutical compositions containing such compounds

Also Published As

Publication number Publication date
ATE89288T1 (de) 1993-05-15
ES2053834T3 (es) 1994-08-01
DE68906437D1 (de) 1993-06-17
IT1216096B (it) 1990-02-22
IT8819783A0 (it) 1988-03-15
EP0332946B1 (de) 1993-05-12
EP0332946A1 (de) 1989-09-20

Similar Documents

Publication Publication Date Title
EP0473084A3 (en) Polyethylene glycol derivatives, their modified peptides, methods for producing them and use of the modified peptides
DE3779500T2 (de) Levodopa-methyl-ester enthaltende pharmazeutische zusammensetzungen, ihre herstellung und therapeutische verwendungen.
DE68903031D1 (de) N-acetyl-3-fluoroneuraminsaeure als antivirales arzneimittel.
DE3781928D1 (de) Arzneimittel mit verzoegerter freisetzung.
DE59309714D1 (de) Pharmazeutische und/oder kosmetische Zubereitung
FR2678938B1 (fr) Derives de pyrrolidine, leur preparation et les medicaments les contenant.
DE69015842T2 (de) Nicotinsäurederivate und diese enthaltende pharmazeutische Zusammensetzungen.
DE69014351D1 (de) Pyridincarbonsäureamid-Derivate und diese enthaltende pharmazeutische Zusammensetzungen.
ATE121295T1 (de) Augentropfenarzneimittel.
DE69006654D1 (de) Einen Zink-Komplex enthaltende Arzneimittel.
SE8404065D0 (sv) Novel biologically active compounds
ATE141605T1 (de) Thienotriazoldiazepinverbindungen und deren pharmazeutische anwendungen
DK0406745T3 (da) Antibiotiske GE 2270 faktorer A1, A2, A3 og H
DE68927055D1 (de) 2',5'-oligoadenylat-derivate zur verwendung als heilmittel
DE68906437D1 (de) L-pyroglutamyl-l-cystein-dipeptid mit hoher anti-cataractogener wirkung und dies enthaltende pharmazeutische zusammensetzungen.
DE240257T1 (de) Verbindungen und pharmazeutische zusammensetzungen mit kalziumregulierender aktivitaet.
DE69024060T2 (de) Osteogenesis-stimulierende mittel.
NO306468B1 (no) Nye fosfolipid-derivater, deres fremstilling, legemiddel inneholdende derivatene og derivatenes anvendelse
DE68922035D1 (de) Glyzerin-Derivat und dessen pharmazeutische Verwendung.
ATE81971T1 (de) Synergistische kombination von decarboxylasehemmern und l-dopa-pellets.
NO890261D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydropyridin-derivater.
DE69111530D1 (de) Pyridincarbonsäure-Amid-Derivate und diese enthaltende pharmazeutische Zusammensetzungen.
ES2162992T3 (es) Uso de 3-alfa-hidroxi-5-alfa-androsta-16-eno como medicamento.
ITRM910829A1 (it) Derivati dell'ipoxantina dotati di attivita' immunomodulante e composizioni farmaceutiche che li contengono.
UA12937A (uk) Засіб для локальhого лікуваhhя гhійhо-запальhих раh та опіків, іhфіковаhих стафілококом

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee